CD40LG and B-cell chronic lymphocytic leukemia: We then tested in vitro the effect of deguelin on CLL-like cells from the spleens of 4 aged NZB mice and 4 transplanted NZB mice (all samples had ≥ 90% B220low CD5low IgM+ leukemic B cells, as assessed by flow cytometry).